Hepatic stellate cell-specific Kcnma1 deletion mitigates metabolic dysfunction-associated steatotic liver disease progression via upregulating Amphiregulin secretion
Yunhan Zou(First Affiliated Hospital of Guangzhou Medical University), Bo Han(Tongren Hospital), Jiaoxiang Wu(Tongren Hospital), Y. Li(Tongren Hospital), Peng Sun(Tongren Hospital), Shangwei Hou(Shanghai Jiao Tong University), Xianbin Su(Shanghai Jiao Tong University), Man Zhang(Shanghai Jiao Tong University), Xin Zhang(China Tobacco), Li Tang(Tongren Hospital), Y Liu(Shandong University), Daqing Cheng(Shanghai Jiao Tong University), Sheng Cheng(Shanghai Jiao Tong University), Jin Zhang(Stomatology Hospital), Xirong Guo
Cited by 1
Related Papers
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
|Cell|2024|272
Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients
|Cell Reports|2021|184
A MicroRNA Signature in Gestational Diabetes Mellitus Associated with Risk of Macrosomia
|Cellular Physiology and Biochemistry|2015|131
Conditional knockin of Dnmt3a R878H initiates acute myeloid leukemia with mTOR pathway involvement
|Proceedings of the National Academy of Sciences|2017|86
Arid1a regulates insulin sensitivity and lipid metabolism
|EBioMedicine|2019|60